Isoplexis company information, Employees & Contact Information

IsoPlexis Reports Preliminary Full Year 2022 Revenue Yahoo Finance

Accelerating decisions in immunotherapy with predictive single-cell response Nature

IsoPlexis Announces Pricing of Initial Public Offering PR Newswire

IsoPlexis’ Functional Proteomics Uncovers Predictive Biomarkers Inside Precision Medicine

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company GlobeNewswire

IsoSpark, IsoLight, and IsoSpark Duo: Accelerating the Next Big Breakthrough in Immune Medicine Genetic Engineering and Biotechnology News

Functional single-cell proteomics firm Isoplexis misses IPO target drugdiscoverytrends.com

Isoplexis takes on cancer, one cell at a time YaleNews

IsoPlexis secures $135M to boost its single-cell protein analysis tech Fierce Biotech

Profile: IsoPlexis Analyzes Thousands of Cells to Fight Cancer IEEE Spectrum

IsoPlexis to Present First-of-Its-Kind Data on Simultaneous Single Cell TCR Profiling and Highly Multiplexed Functional Proteomics at AACR 2022 Yahoo Finance

ISO IPO News - Proteomics platform IsoPlexis files for a $100 million IPO renaissancecapital.com

Duomic: IsoPlexis Introduces Integrated Single-Cell Functional Multi-omic Biology Platform BioSpace

Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools the-scientist.com

IsoPlexis Nets $111M from IPO to Expand Platform, Product Offerings, Distribution Network Genetic Engineering and Biotechnology News

IsoPlexis Launches Personalized Lab System, the IsoSpark, to Continue Scaling to Many Labs Worldwide PR Newswire

BPI News: Bruker to Acquire PhenomeX, a Merger of Berkeley Lights and IsoPlexis Genetic Engineering and Biotechnology News

Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company PR Newswire

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut TechCrunch

IsoPlexis and Miltenyi Report on Synergistic CAR-T Cell Technologies Genetic Engineering and Biotechnology News

A Functional Cell Biology Company Is Formed Genetic Engineering and Biotechnology News

Berkeley Lights Agrees to $57.8 Million Deal for IsoPlexis Bloomberg

IsoPlexis Appoints Nachum “Homi” Shamir to its Board of Directors citybiz

Branford company developing cancer-fighting therapy seeks $100 million public stock offering New Haven Register

Searching for Superhero Cells: IsoPlexis leverages new tech to fight diseases Hartford Business Journal

IsoPlexis appoints new board member Hartford Business Journal

IsoPlexis Wins $1.8M NCI SBIR Grant toward Platform to Assess CAR-T Therapies Inside Precision Medicine

IsoPlexis Appoints Richard Rew as Senior VP, General Counsel and Raj Khakhar as VP of Finance citybiz

IsoPlexis’ New Software Designed for Better Insights on Single-Cell Immune Activation Genetic Engineering and Biotechnology News

IsoPlexis Launches Suite of New Products Enabling Multiple Automated Applications on the IsoLight BioSpace

IsoPlexis (ISO) Stock Price, News & Analysis MarketBeat

Precipio partners with Israeli AI firm; Calif. drug maker taps IsoPlexis technology Hartford Business Journal